New England Asset Management Inc. Continues to Hold Stake in Becton, Dickinson and Company (NYSE:BDX)

New England Asset Management Inc. continued to hold its position in Becton, Dickinson and Company (NYSE:BDX) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,085 shares of the medical instruments supplier’s stock at the end of the first quarter. New England Asset Management Inc.’s holdings in Becton, Dickinson and were worth $199,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Cypress Capital Group raised its position in Becton, Dickinson and by 84.6% in the first quarter. Cypress Capital Group now owns 4,615 shares of the medical instruments supplier’s stock worth $847,000 after buying an additional 2,115 shares in the last quarter. Signaturefd LLC raised its position in Becton, Dickinson and by 17.0% in the first quarter. Signaturefd LLC now owns 2,361 shares of the medical instruments supplier’s stock worth $433,000 after buying an additional 343 shares in the last quarter. Sii Investments Inc. WI raised its position in Becton, Dickinson and by 14.1% in the first quarter. Sii Investments Inc. WI now owns 1,700 shares of the medical instruments supplier’s stock worth $311,000 after buying an additional 210 shares in the last quarter. Level Four Advisory Services LLC raised its position in Becton, Dickinson and by 23.1% in the first quarter. Level Four Advisory Services LLC now owns 3,634 shares of the medical instruments supplier’s stock worth $666,000 after buying an additional 683 shares in the last quarter. Finally, Two Sigma Securities LLC bought a new position in Becton, Dickinson and during the first quarter worth about $493,000. Institutional investors and hedge funds own 75.71% of the company’s stock.

Shares of Becton, Dickinson and Company (NYSE:BDX) traded up 0.34% on Thursday, reaching $198.51. The company’s stock had a trading volume of 264,499 shares. Becton, Dickinson and Company has a 52 week low of $161.29 and a 52 week high of $206.63. The stock has a market capitalization of $45.17 billion, a price-to-earnings ratio of 57.49 and a beta of 1.05. The stock has a 50-day moving average of $198.62 and a 200 day moving average of $187.41.

Becton, Dickinson and (NYSE:BDX) last released its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, topping the Zacks’ consensus estimate of $2.44 by $0.02. The business had revenue of $3.04 billion for the quarter, compared to analyst estimates of $3.06 billion. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. Becton, Dickinson and’s revenue for the quarter was down 5.1% on a year-over-year basis. During the same period in the prior year, the company earned $2.35 EPS. On average, analysts expect that Becton, Dickinson and Company will post $9.45 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 8th will be given a $0.73 dividend. The ex-dividend date is Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a yield of 1.48%. Becton, Dickinson and’s payout ratio is 83.43%.

WARNING: This piece was posted by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/2800307/new-england-asset-management-inc-continues-to-hold-stake-in-becton-dickinson-and-company-nysebdx.html.

A number of research analysts recently issued reports on the company. Stifel Nicolaus restated a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday. Zacks Investment Research lowered Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Monday. BidaskClub lowered Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Sunday. Bank of America Corporation restated a “buy” rating and set a $225.00 price objective (up previously from $200.00) on shares of Becton, Dickinson and in a research report on Friday, July 21st. Finally, Cowen and Company restated an “outperform” rating and set a $230.00 price objective (up previously from $200.00) on shares of Becton, Dickinson and in a research report on Monday, July 10th. One research analyst has rated the stock with a sell rating, five have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. Becton, Dickinson and currently has a consensus rating of “Buy” and a consensus target price of $194.69.

In other Becton, Dickinson and news, VP Jeffrey S. Sherman sold 28,765 shares of the stock in a transaction on Thursday, May 25th. The stock was sold at an average price of $185.98, for a total value of $5,349,714.70. Following the transaction, the vice president now directly owns 70,821 shares in the company, valued at approximately $13,171,289.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.40% of the stock is currently owned by company insiders.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.